August 28, 2014
The Central Social Insurance Medical Council (Chuikyo) approved the inclusion of a record 22 active pharmaceutical ingredients (APIs)/33 products including Ono Pharmaceutical’s anticancer drug Opdivo (nivolumab (recombinant)), which received the world’s first approval in Japan in early July, to the...read more